Learn, Analyse & Invest
only with
only with
+91
Download Orca
Novelix Pharmaceuticals Ltd.
Novelix Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹1.16 Cr.
| EX-Date | Purpose |
|---|---|
| 21 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 27 01 2022 | Inter alia, to consider and approve : 1. To consider the sale of shares/assets of the wholly owned subsidiary of the Company M/s. Trimurthi Foods Limited. 2. Any other business with the permission of the Chair. |
| 12 02 2022 | Quarterly Results |
| 28 05 2022 | Audited Results |
| 10 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 09 02 2023 | Quarterly Results |
| 29 04 2023 | Audited Results |
| 09 08 2023 | Quarterly Results |
| 17 10 2023 | Quarterly Results |
| 15 12 2023 | Quarterly Results |
| 30 01 2024 | Quarterly Results |
| 05 03 2024 | Preferential Issue of shares |
| 14 10 2024 | Issue Of Warrants & Increase in Authorised Capital |
| 21 10 2024 | Issue of Warrants (Revised) |
| 13 11 2024 | Quarterly Results & Inter-alia to discuss the following: 1. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter and half year ended 30th September 2024. 2. To consider and approve the appointment of the Director of the Company. 3. Any other item with the approval of the chairman. |
| 12 02 2025 | Quarterly Results |
| 12 04 2025 | Inter alia, to consider and approve:- 1. To consider and approve the convening of an EGM for seeking shareholder approval for the confirmation of appointment of Mr. Laxman Samala as Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for to scrutinize the voting process for the upcoming EGM. 3. Any other item with the approval of the chairman. |
| 27 05 2025 | Audited Results |
| 24 06 2025 | Inter alia, to consider and approve the conversion of Warrants into Equity Shares of the Company. |
| 14 08 2025 | Quarterly Results & A.G.M. |
| 13 11 2025 | Quarterly Results |
| 11 12 2025 | Preferential Issue of shares & Inter alia, to consider and approve:- 1) To consider and if thought fit, approve the issuance of securities of the Company on a preferential basis in accordance with the Companies Act, 2013 read with the rules notified thereunder, each as amended, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and such other acts, rules and regulations, as may be applicable, subject to any regulatory/ statutory approvals, as may be required and the approval of the shareholders of the Company. 2) To adopt and approve the Draft Notice of Extra Ordinary General Meeting of the Company. 3) To fix the day, date, time and venue of Extra Ordinary General Meeting of the Company. 4) To appoint Scrutinizer for conducting E- voting process for Extra Ordinary General Meeting. 5) Any other Matter with the permission of the chair. |
| 12 02 2026 | Quarterly Results |
News
